Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Dai

Showing results (101-110 of 270) with videos related to

Pageof 27
Sort By:
Journal of Clinical Gastroenterology|July 19, 2014
Fecal microbiota transplantation for treatment of Clostridium difficile infectionCong Dai, Min Jiang, Ming-jun Sun
Journal of Clinical Gastroenterology|June 12, 2013
Efficacy of probiotics in Helicobacter pylori eradication therapyCong Dai, Chang-Qing Zheng, Min Jiang
Hepato-Gastroenterology|February 24, 2016
Anti-TNF-A Therapy about Infliximab and Adalimamab for the Effectiveness in Ulcerative Colitis Compared with Conventional Therapy: A Meta-AnalysisZheng Zhou, Cong Dai, Wei-xin Liu
International Immunopharmacology|December 12, 2022
Combination therapy in inflammatory bowel disease: Current evidence and perspectivesCong Dai, Yu-Hong Huang, Min Jiang
Inflammatory Bowel Diseases|July 14, 2021
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Yu-Hong Huang
The American Journal of Gastroenterology|December 8, 2016
Statins and the Risk of Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Digestive Diseases and Sciences|March 5, 2019
High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Mbio|July 2, 2024
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathwayYing-Jie Li, Jing Li, Cong Dai
JAMA|May 13, 2026
Antibiotics for Uncomplicated Acute AppendicitisCong Dai, Min Jiang, Yu-Hong Huang
Alimentary Pharmacology & Therapeutics|September 19, 2019
Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than IBDCong Dai, Min Jiang, Ming-Jun Sun
Pageof 27

Showing results (101-110 of 270) with videos related to

Sort By:
Pageof 27
Journal of Clinical Gastroenterology|July 19, 2014
Fecal microbiota transplantation for treatment of Clostridium difficile infectionCong Dai, Min Jiang, Ming-jun Sun
Journal of Clinical Gastroenterology|June 12, 2013
Efficacy of probiotics in Helicobacter pylori eradication therapyCong Dai, Chang-Qing Zheng, Min Jiang
Hepato-Gastroenterology|February 24, 2016
Anti-TNF-A Therapy about Infliximab and Adalimamab for the Effectiveness in Ulcerative Colitis Compared with Conventional Therapy: A Meta-AnalysisZheng Zhou, Cong Dai, Wei-xin Liu
International Immunopharmacology|December 12, 2022
Combination therapy in inflammatory bowel disease: Current evidence and perspectivesCong Dai, Yu-Hong Huang, Min Jiang
Inflammatory Bowel Diseases|July 14, 2021
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Yu-Hong Huang
The American Journal of Gastroenterology|December 8, 2016
Statins and the Risk of Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Digestive Diseases and Sciences|March 5, 2019
High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Mbio|July 2, 2024
Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathwayYing-Jie Li, Jing Li, Cong Dai
JAMA|May 13, 2026
Antibiotics for Uncomplicated Acute AppendicitisCong Dai, Min Jiang, Yu-Hong Huang
Alimentary Pharmacology & Therapeutics|September 19, 2019
Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than IBDCong Dai, Min Jiang, Ming-Jun Sun
Pageof 27